Psychiatry & Mental Health Clinical Trials

Statistical methods in psychiatry & mental health trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All psychiatry & mental health trials

521 results

• A Study of Mobile Medical Supportive Care Program for Family Caregivers With Dementia Combined With Diabetes: Complete Statistical AnalysisIndependent statistical analysis of A Study of Mobile Medical Supportive Care Program for Family Caregivers With Dementia Combined With Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 60NCT06785857
• A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression: Complete Statistical AnalysisIndependent statistical analysis of A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 81NCT03044249
• A Study of Paliperidone Palmitate 6-Month Formulation: Complete Statistical AnalysisIndependent statistical analysis of A Study of Paliperidone Palmitate 6-Month Formulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03345342).Phase 3Results postedn = 841NCT03345342
• A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 191NCT00930059
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02): Complete Statistical AnalysisIndependent statistical analysis of A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 658NCT02943564
• A Study of the Effect of LY2216684 on Lorazepam: Complete Statistical AnalysisIndependent statistical analysis of A Study of the Effect of LY2216684 on Lorazepam: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01275144).Phase 1Results postedn = 28NCT01275144
• A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes: Complete Statistical AnalysisIndependent statistical analysis of A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 559NCT00132678
• A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson’s Disease Psychosis: Complete Statistical AnalysisIndependent statistical analysis of A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 298NCT00477672
• A Study of V950 in People With Alzheimer Disease (V950-001 AM7): Complete Statistical AnalysisIndependent statistical analysis of A Study of V950 in People With Alzheimer Disease (V950-001 AM7): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 86NCT00464334
• A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration: Complete Statistical AnalysisIndependent statistical analysis of A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 27NCT01453374
• A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase NAResults postedn = 28NCT02526277
• A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.: Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1Results postedn = 45NCT05587998
• A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 24NCT04622527
• A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted: Complete Statistical AnalysisIndependent statistical analysis of A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted: primary endpoint results, effect estimate with…Phase 1Results postedn = 45NCT01775189
• A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate 3 Dose Levels of Luvadaxistat of Adults With Negative Symptoms of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 256NCT03382639
• A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder: primary…Phase 3Results postedn = 491NCT03107026
• A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate Effectiveness and Safety of ER OROS Paliperidone in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 3Results postedn = 394NCT00396565
• A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone: primary endpoint…Phase 4Results postedn = 223NCT01010776
• A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 35NCT03692910
• A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington’s Disease (HD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 189NCT05107128
• A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 360NCT03446846
• A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 245NCT02969382
• A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 51NCT03093025
• A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia: primary…Phase 1Results postedn = 17NCT06107803
• A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD): primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 339NCT02901431
• A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.: Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on…Phase 2Results postedn = 518NCT02281773
• A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 72NCT00475735
• A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1Results postedn = 110NCT02566759
• A Transdiagnostic Course for Common Mental Health Problems in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of A Transdiagnostic Course for Common Mental Health Problems in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 91NCT04522713
• A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians: Complete Statistical AnalysisIndependent statistical analysis of A Trial Comparing Approaches to Shared Decision Making Skills Training for Clinicians: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 23NCT02871739
• A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1/2Results postedn = 266NCT04030143
• A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: primary endpoint results, effect estimate with confidence…Phase 3Results postedn = 1,149NCT03538691
• A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 3Results postedn = 188NCT01606228
• A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and…Phase 4Results postedn = 2NCT03643159
• A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: Complete Statistical AnalysisIndependent statistical analysis of A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 1/2Results postedn = 12NCT01136356
• ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: Complete Statistical AnalysisIndependent statistical analysis of ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 53NCT05574764
• ABSORB (Amount of Blueberries So Older Adults Reap Benefits): Complete Statistical AnalysisIndependent statistical analysis of ABSORB (Amount of Blueberries So Older Adults Reap Benefits): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05937165).Phase NAResults postedn = 6NCT05937165
• Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: Complete Statistical AnalysisIndependent statistical analysis of Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 44NCT01759446
• Acamprosate to Reduce Symptoms of Alcohol Withdrawal: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate to Reduce Symptoms of Alcohol Withdrawal: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00106106).Phase 2Results postedn = 56NCT00106106
• Acamprosate vs. Placebo in Bipolar Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Acamprosate vs. Placebo in Bipolar Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466661).Phase 4Results postedn = 33NCT00466661
• Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058249).Phase NAResults postedn = 1NCT04058249
• Accelerating Word Learning in Children With Language Impairment: Complete Statistical AnalysisIndependent statistical analysis of Accelerating Word Learning in Children With Language Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01829360).Phase NAResults postedn = 35NCT01829360
• Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values: Complete Statistical AnalysisIndependent statistical analysis of Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 55NCT02722564
• ACESIndependent statistical analysis of ASPIRE Cognitive Enhancement Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02657954).Phase NAResults postedn = 79NCT02657954
• ACHIEVE2Independent statistical analysis of Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 4Results postedn = 30NCT00696293
• ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: Complete Statistical AnalysisIndependent statistical analysis of ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 70NCT02751983
• ACT-IPIndependent statistical analysis of Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01981356).Phase EARLY_1Results postedn = 18NCT01981356
• Actigraphic Analysis of Treatment Response: Complete Statistical AnalysisIndependent statistical analysis of Actigraphic Analysis of Treatment Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00723580).Phase NAResults postedn = 1NCT00723580
• ACTIONIndependent statistical analysis of Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24…Phase 4Results postedn = 716NCT00948766
• ACTIVEIndependent statistical analysis of ACTIVE: Advanced Cognitive Training for Independent and Vital Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298558).Phase 2/3Results postedn = 2,832NCT00298558

← All therapeutic areas